Clinical trial
Effects of BufferGel and PRO 2000/5 Gel in Men
NCT00016536 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00016536 |
|---|---|
| Title | Effects of BufferGel and PRO 2000/5 Gel in Men |
| Official title | Male Tolerance Study of BufferGel and PRO 2000/5 Gel (P) |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Naphthalene 2-sulfonate polymer, Carbopol polymer |
| Enrollment | 24 |
| Completion | May 1, 1997 |
| First posted | Aug 31, 2001 |
| Last update posted | Nov 1, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: